Orteronel(TAK-700)是已进入临床三期的用于治疗去势抵抗性前列腺癌的化合物。A steroid 17,20-lyase inhibitor with efficacy in rat, monkey, and human cells. Orteronel(TAK-700) was selected as a candidate for clinical evaluation. orteronel (TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer. A steroid 17,20-lyase inhibitor with efficacy in rat, monkey, and human cells.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Orteronel
Dangerous GoodsCAS number:566939-85-3 molecular formula:C18H17N3O2
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | 6-[(7S)-7-hydroxy-5H,6H,7H-pyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide | 2-NAPHTHALENECARBOXAMIDE, 6-((7S)-6,7-DIHYDRO-7-HYDROXY-5H-PYRROLO(1,2-C)IMIDAZOL-7-YL)-N-METHYL- | Orteronel [INN] | 6-[(7s)-7-hydroxy-6,7-dihydro-5h-pyrrolo[1,2- | ||
| CAS number | 566939-85-3 | molecular formula | C18H17N3O2 |
| molecular weight | 307.35 g/mol | Exact mass | ≥99% |
| PSA | 67.200 Ų | logp | 1.3 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS08
Signal word:
Danger
Hazard Statement:
H372: 通过长时间或反复暴露对器官造成损害 H361: 怀疑破坏生育力或未出生的孩子
Statement of Preventive Measures:
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P203: 使用前,获取、阅读并遵守所有安全说明。 P318: 如果暴露或担心,请就医。 P319: 如果你感到不适,请寻求医疗帮助。
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





